Latanoprost-related eye color changes may take several months to years to appear, and there is no predictable timeline for an individual. The change, when it occurs, is usually an increase in brown pigmentation in the iris—the colored part of the eye—not an immediate or guaranteed change in overall eye color. Not everyone will notice a change.
How long does latanoprost take to change eye color?
The timing varies. The Mayo Clinic’s latanoprost guidance describes iris darkening as a gradual change that may become noticeable within several months or years after treatment begins. There is no fixed deadline by which it will happen, and some people may not see a noticeable difference.
Latanoprost can increase brown pigmentation in the iris. This is different from a quick shift in the eye’s entire color. The change may be subtle at first, so a person may not immediately notice it.
Why can latanoprost darken the iris?
The reported change is an increase in brown pigmentation in the iris. Mayo Clinic notes that it is more likely to occur in eyes with mixed colors, including blue-brown, gray-brown, green-brown, or yellow-brown. That does not mean a change is certain for people with those eye colors, or that people with other eye colors cannot experience one.
Patient guidance describes the pigmentation change but does not establish a precise biological mechanism. If you think your eye color is changing, raise it with your eye-care professional so they can assess the change and your treatment.
Can the color change or other visible effects be permanent?
Iris darkening may be permanent, even after latanoprost is stopped. The WebMD latanoprost medication information also notes that the change may take months to years to develop and may remain after treatment ends. Do not stop prescribed drops on your own; ask your prescriber what to do if the change concerns you.
Other visible effects are not necessarily the same. Latanoprost may also darken eyelid skin or change eyelashes, such as making them longer, thicker, or darker. These eyelid and eyelash changes may return toward normal after stopping treatment, according to Mayo Clinic. The duration of one effect should not be assumed to apply to every possible side effect. Contact your eye-care professional about any symptom that bothers you or seems unexpected.
How soon does latanoprost start working?
Latanoprost’s effect on eye pressure has a much faster timeline than a visible iris color change. The NHS says the drops should begin to reduce pressure within 3 to 4 hours. That timeframe refers to pressure inside the eye—not to a change in iris pigmentation, and it does not mean that an individual’s pressure has reached its treatment goal.
How should latanoprost be stored?
Storage instructions depend on the exact product and formulation, so there is no single refrigerator duration or after-opening limit that applies to every latanoprost product. For example, the NHS guidance on latanoprost says an opened bottle lasts for up to four weeks, while Mayo Clinic’s instructions for Xalatan describe an opened bottle as usable for up to six weeks when stored in the refrigerator or at room temperature. These are product-specific directions, not interchangeable rules.
Check the leaflet for your own bottle for both unopened storage and how long it can be used after opening. If the instructions are unclear, ask a pharmacist. Do not rely on the refrigerator alone to determine whether an opened bottle is still suitable to use.
Latanoprost precautions to know
Follow the directions for your specific prescription and product. Mayo Clinic advises removing contact lenses before using the drops and waiting at least 15 minutes before putting them back in. If you use other eye medicines, its guidance says to leave at least five minutes between them.
These points are not a complete list of who should or should not use latanoprost. Tell your prescriber or pharmacist about allergies, other medical conditions, and any other medicines you use, and consult the product leaflet for warnings specific to your formulation. Mayo Clinic notes that safety and effectiveness have not been established in the pediatric population; a clinician should advise on treatment for a child.